Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Invested Capital (2016 - 2017)

Historic Invested Capital for Tenax Therapeutics (TENX) over the last 7 years, with Q3 2017 value amounting to $10.2 million.

  • Tenax Therapeutics' Invested Capital fell 7823.15% to $10.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was $10.2 million, marking a year-over-year decrease of 7823.15%. This contributed to the annual value of $17.1 million for FY2016, which is N/A changed from last year.
  • As of Q3 2017, Tenax Therapeutics' Invested Capital stood at $10.2 million, which was down 7823.15% from $11.3 million recorded in Q2 2017.
  • Tenax Therapeutics' Invested Capital's 5-year high stood at $82.9 million during Q2 2014, with a 5-year trough of -$1.8 million in Q2 2013.
  • Over the past 5 years, Tenax Therapeutics' median Invested Capital value was $17.1 million (recorded in 2016), while the average stood at $32.8 million.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 41381.49% in 2013, then skyrocketed by 475993.72% in 2014.
  • Over the past 5 years, Tenax Therapeutics' Invested Capital (Quarter) stood at -$1.8 million in 2013, then surged by 4759.94% to $82.9 million in 2014, then dropped by 27.07% to $60.4 million in 2015, then crashed by 71.63% to $17.1 million in 2016, then tumbled by 40.7% to $10.2 million in 2017.
  • Its last three reported values are $10.2 million in Q3 2017, $11.3 million for Q2 2017, and $14.1 million during Q1 2017.